BiotechTube
Home/Pipeline/ACTOnco® IVD

ACTOnco® IVD

Solid Tumors

CommercialActive

Key Facts

Indication
Solid Tumors
Phase
Commercial
Status
Active
Company
ACT Genomics

About ACT Genomics

ACT Genomics delivers NGS‑based genomic profiling to personalize cancer treatment across Asia.

View full company profile

Therapeutic Areas

Oncology

Other Solid Tumors Drugs

DrugCompanyPhase
APVO603Aptevo TherapeuticsPreclinical
APVO711Aptevo TherapeuticsPreclinical
Platform-derived ImmunotherapyGenCirqPre-clinical
SP-2-225Shuttle PharmaceuticalsPreclinical
SP-1-161Shuttle PharmaceuticalsPreclinical
CAR-T Solid Tumor ProgramCarina BiotechPhase 1/2a
HBM1020Harbour BioMedPhase 1
HBM7022Harbour BioMedPhase 1
HBM9033Harbour BioMedDiscovery
Undisclosed Whole Cell Vaccine Program(s)NeuvogenPre-clinical
SY-5609Syros PharmaceuticalsPhase 1/2
Not Specified (TCR Therapy)T-Cure BiosciencePhase 1